BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31107116)

  • 1. Challenges in pulmonary hypertension associated with left heart disease.
    Zolty R
    Expert Rev Cardiovasc Ther; 2019 Jun; 17(6):461-472. PubMed ID: 31107116
    [No Abstract]   [Full Text] [Related]  

  • 2. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Hypertension secondary to Left Heart Disease.
    Kabbach G; Mukherjee D
    Curr Vasc Pharmacol; 2018; 16(6):555-560. PubMed ID: 28901848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Pulmonary Hypertension in Left Heart Disease.
    Guha A; Amione-Guerra J; Park MH
    Prog Cardiovasc Dis; 2016; 59(1):3-10. PubMed ID: 27402130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor.
    Benza RL; Raina A; Abraham WT; Adamson PB; Lindenfeld J; Miller AB; Bourge RC; Bauman J; Yadav J
    J Heart Lung Transplant; 2015 Mar; 34(3):329-37. PubMed ID: 24999252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
    Chung K; Strange G; Codde J; Celermajer D; Scalia GM; Playford D
    Heart Lung Circ; 2018 Mar; 27(3):301-309. PubMed ID: 29102471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.
    Guazzi M; Labate V
    Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Wood KC; Gladwin MT; Straub AC
    Heart; 2020 Apr; 106(8):562-568. PubMed ID: 31822569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction.
    Dixon DD; Trivedi A; Shah SJ
    Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    Guazzi M; Ghio S; Adir Y
    J Am Coll Cardiol; 2020 Sep; 76(9):1102-1111. PubMed ID: 32854845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension secondary to heart failure with preserved ejection fraction.
    Thenappan T; Prins KW; Cogswell R; Shah SJ
    Can J Cardiol; 2015 Apr; 31(4):430-9. PubMed ID: 25840094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.